Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

GCT Semiconductor Q1 Earnings Call Highlights

GCT Semiconductor (NYSE:GCTS) reported higher first-quarter revenue and said its 5G chipset commercialization efforts continued to gain traction, with management pointing to increased shipments, broader customer engagement and progress across fixed wireless access, Internet of Things and non-terrest

MarketBeat

Andersen Group Q1 Earnings Call Highlights

Andersen Group (NYSE:ANDG) reported first-quarter 2026 revenue and adjusted EBITDA above its prior guidance, with management pointing to broad-based organic growth across tax service lines, higher revenue per professional and an active acquisition pipeline expected to contribute more meaningfully in

MarketBeat

Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations

Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected first-quarter trends across medical costs, free cash flow and revenue. Speaking at a Bank of America healthc

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

a.k.a. Brands Q1 Earnings Call Highlights

a.k.a. Brands (NYSE:AKA) reported a stronger-than-expected start to fiscal 2026, with first-quarter net sales rising 3% to $132.5 million and Adjusted EBITDA increasing to $5.1 million, management said on the company’s earnings call. Chief Executive Officer Ciaran Long said the results reflected “s

MarketBeat

Upexi Q3 Earnings Call Highlights

Upexi (NASDAQ:UPXI) reported higher fiscal third-quarter revenue but a large net loss tied primarily to unrealized losses on its Solana holdings, as management said a weak crypto market weighed on both token prices and industry valuation multiples during the quarter ended March 31, 2026. Chief Exec

MarketBeat

Verrica Pharmaceuticals Q1 Earnings Call Highlights

Verrica Pharmaceuticals (NASDAQ:VRCA) reported higher first-quarter revenue and record demand for its molluscum contagiosum treatment YCANTH, while outlining progress on late-stage development programs in common warts and basal cell carcinoma. President and Chief Executive Officer Jayson Rieger sai

MarketBeat

TriSalus Life Sciences Q1 Earnings Call Highlights

TriSalus Life Sciences (NASDAQ:TLSI) reported slightly lower first-quarter revenue and reduced its full-year 2026 revenue outlook, citing disruption from a broad commercial reorganization and a delayed FDA review for its next-generation TriNav Advance device. President and Chief Executive Officer M

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

OptimizeRx Q1 Earnings Call Highlights

OptimizeRx (NASDAQ:OPRX) reported first-quarter fiscal 2026 results that topped consensus expectations, while management lowered its full-year revenue outlook, citing continued caution among life sciences customers and shorter contract commitments tied in part to most-favored-nation pricing dynamics

MarketBeat

QuickLogic Q1 Earnings Call Highlights

QuickLogic (NASDAQ:QUIK) reported higher first-quarter fiscal 2026 revenue and reiterated expectations for strong full-year growth, as management highlighted progress in radiation-hardened FPGA products, embedded FPGA intellectual property and chiplet-related opportunities. President and Chief Exec

MarketBeat

Paysign Q1 Earnings Call Highlights

Paysign (NASDAQ:PAYS) reported what executives described as the strongest start to a year in the company’s history, with first-quarter 2026 revenue rising 50.8% year over year to $28 million and profitability expanding sharply as its patient affordability business became its largest revenue contribu

MarketBeat

Relmada Therapeutics Q1 Earnings Call Highlights

Relmada Therapeutics (NASDAQ:RLMD) said it remains on track to begin its Phase 3 RESCUE registrational program for NDV-01 in mid-2026 after reporting 12-month Phase 2 data in non-muscle invasive bladder cancer and strengthening its balance sheet through a private financing. On the company’s first-q

MarketBeat

NeuroPace Q1 Earnings Call Highlights

NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution across epilepsy treatment centers. The company reported total revenue of $22.1 million for the first qu

MarketBeat

Nyxoah Q1 Earnings Call Highlights

Nyxoah (NASDAQ:NYXH) reported 13% sequential worldwide net revenue growth in the first quarter of 2026, driven primarily by continued adoption of its Genio system in the United States, where the company is in its second full quarter of commercialization. Chief Executive Officer Olivier Taelman said

MarketBeat

Nextpower Q4 Earnings Call Highlights

Nextpower (NASDAQ:NXT) reported a strong finish to fiscal 2026, with executives pointing to record backlog, growth in its core solar tracker business and a broader push into power plant technology as key themes for the year ahead. Chief Executive Officer and Founder Dan Shugar said the company deli

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

National CineMedia Q1 Earnings Call Highlights

National CineMedia (NASDAQ:NCMI) reported first-quarter 2026 results that management said were in line with expectations, as the cinema advertising company faced typical seasonal weakness, advertising competition from the Winter Olympics and a one-week fiscal calendar shift. Chief Executive Officer

MarketBeat

MaxCyte Q1 Earnings Call Highlights

MaxCyte (NASDAQ:MXCT) reported lower first-quarter revenue compared with the prior year, as management said discontinued SPL programs and inventory management by its largest customer weighed on core revenue, while milestone revenue from a registrational-stage program helped offset part of the declin

MarketBeat

Spectral AI Q1 Earnings Call Highlights

Spectral AI (NASDAQ:MDAI) said it remains on track toward potential U.S. regulatory clearance and commercialization of its DeepView system for burn assessment, while reporting lower first-quarter research and development revenue tied to the completion of work under a federal contract. On the compan

MarketBeat

Kura Oncology Q1 Earnings Call Highlights

Kura Oncology (NASDAQ:KURA) reported $5.8 million in first-quarter net product revenue from KOMZIFTI, its first commercial product, and said the launch is showing early signs of physician uptake, broad payer coverage and use in combination regimens, according to management’s earnings call for the fi

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Lumexa Imaging Q1 Earnings Call Highlights

Lumexa Imaging (NASDAQ:LMRI) reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and weather-related disruptions. Chief Executive Officer Caitlin Zulla said the company “recovered our mom

MarketBeat

ACADIA Pharmaceuticals Targets $1B Brand Opportunity as Key Neuropsychiatry Data Looms

ACADIA Pharmaceuticals (NASDAQ:ACAD) executives said the company is focused on expanding its two commercial brands while preparing for several clinical data readouts in neuropsychiatric disorders, according to comments at the Bank of America Global Healthcare Conference. Chief Executive Officer Cat

MarketBeat

Izea Worldwide Q1 Earnings Call Highlights

Izea Worldwide (NASDAQ:IZEA) reported lower first-quarter 2026 revenue as the influencer marketing company said it completed a strategic shift away from small and midsize business accounts and toward larger enterprise clients. Chief Executive Officer Patrick Venetucci told investors that the compan

MarketBeat

Intellicheck Mobilisa Q1 Earnings Call Highlights

Intellicheck Mobilisa (NASDAQ:IDN) reported higher first-quarter revenue and profitability, with management saying growth in banking and lending helped offset weaker transaction volumes in retail, automotive and title insurance amid a challenging macroeconomic backdrop. President and CEO Bryan Lewi

MarketBeat

Hyperfine Q1 Earnings Call Highlights

Hyperfine (NASDAQ:HYPR) reported a sharp year-over-year increase in first-quarter revenue and reiterated its full-year 2026 outlook, as management pointed to continued adoption of its next-generation Swoop portable MRI system across hospitals, neurology offices and international markets. President

MarketBeat

HireQuest Q1 Earnings Call Highlights

HireQuest (NASDAQ:HQI) reported lower first-quarter revenue following the divestiture of certain MRI Network assets, while management said demand trends improved as the quarter progressed and have become more favorable early in the second quarter. Chief Executive Officer Rick Hermanns described the

MarketBeat

Fractyl Health Q1 Earnings Call Highlights

Fractyl Health (NASDAQ:GUTS) said it remains on track to report pivotal data for its Revita therapy in early fourth quarter 2026, as management highlighted clinical, regulatory and reimbursement developments during the company’s first-quarter 2026 earnings call. Chief Executive Officer Dr. Harith R

1 … 32 33 34 35

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Intellectual Property

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.